Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIFEDIPINE vs NIRAPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIFEDIPINE vs NIRAPARIB: Safety Overview

Metric NIFEDIPINE NIRAPARIB
Total FAERS Reports 8,266 21,634
Deaths Reported 1,081 1,370
Death Rate 13.1% 6.3%
Hospitalizations 2,637 4,892
Average Patient Age 54.2 yrs 65.7 yrs
% Female Patients 66.5% 98.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 26, 2023
Manufacturer Cardinal Health 107, LLC GlaxoSmithKline LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued